Coya Therapeutics, Inc. (COYA) stock
COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)
Close on Nov 17, 2026Market cap $70.84MP/E –Yield –
Coya Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Coya Therapeutics's price to sales ratio was 9.4× on Nov 11, 2026, against 27.3× a year earlier. Over the last 3 years it ranged from 9.1× to 259.1×, with a median of 17.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.4× | −15.0 |
| 2025 | Dec 31, 2025 | 24.4× | +15.2 |
| 2024 | Dec 31, 2024 | 9.1× | – |
See a number that looks wrong?